FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
Interpace Diagnostics ®, a subsidiary of Interpace Biosciences ®, (“Interpace” or the “Company”) (OTCQX: IDXG) today announced notification that the Centers for Medicare & Medicaid Services (CMS) ...
Certain untreated lung cancer patients on England's NHS will ... over the price of the cystic fibrosis drug Orkambi that was only recently resolved through a specialised pricing deal.
Learn more about whether Natera, Inc. or Vertex Pharmaceuticals Incorporated is a better investment based on AAII's A+ ...
Zacks.com on MSN13h
Roche's 2024 Sales and Earnings Beat, Key Drugs Perform WellSwiss pharma giant Roche Holding AG RHHBY posted better-than-expected 2024 results and provided an encouraging outlook for ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
As Queensland's doctors battle it out with the Newman government over contracts and conditions, patients have been caught in the middle.
Interpace Diagnostics®, a subsidiary of Interpace Biosciences®, ("Interpace" or the "Company") (OTCQX: IDXG) today announced notification that the Centers ...
BuzzFeed on MSN6d
"There Were Almost No Signs At All": People Are Sharing Small Medical Symptoms That Turned Out To Be Indicators Of Major ProblemsI started feeling even more exhausted than usual. I also had lower back and abdominal pain and bloating, but I shrugged it off because women just have to deal with that..." ...
7.“A few months after getting H1N1 flu, I started sleeping for very long periods of time (up to 20 hours, sometimes two days ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback